Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exon skipping oligomer conjugates for muscular dystrophy

Exon skipping oligomer conjugates for muscular dystrophy

US Patent 11491238 · Granted Nov 8, 2022

Estimated economic value: $84,008,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligomers and methods of using the same for treating diseases associat2024
Exon skipping compositions for treating muscular dystrophy2024
Methods of installing fasteners and apparatus relating thereto2023
Oligonucleotide analogues targeting human LMNA2023
Antisense oligomer compounds2023
Processes for preparing oligomers2022
Exon skipping oligomer conjugates for muscular dystrophy2022
Antisense-induced exon2 inclusion in acid alpha-glucosidase2022
Oligonucleotide analogues targeting human LMNA2021
Antisense oligomers and methods of using the same for treating diseases associat2021
Methods and compounds for treatment of lymphocyte-related diseases and condition2021
Antisense-induced exon exclusion in myostatin2021